Novel partnerships with decentralized healthcare and clinical research capabilities will revolutionize the landscape of clinical research. This unprecedented approach enables BARDA and MCM developers to conduct clinical trials with enhanced efficiency and relevance while increasing access and participation among diverse patient populations.

These advancements will facilitate more robust and representative clinical research by enabling comprehensive and regular collection, including patient-generated and patient-reported data. Data collection can occur over longer time frames and in real-world settings, providing a holistic understanding of disease etiology, progression, and outcomes.

This evolution in clinical trials will bring a future where clinical trials are more accessible and inclusive, resulting in novel and effective MCMs.